The Media Database That Really Understands Journalists

Explore Our Database And See What Journalists Create So You Can Better Connect 🫶

Find Out More
Login
Free Trial

Media Database A acs.org Alla Katsnelson

Alla Katsnelson
lalakat

1088 followers

Southampton, MA

Science journalist based in Western Mass. @UCSC_SciCom alum. Writing for @cenmag, @knowablemag, @nytimes, @sciencemagazine, @MensHealthMag, and more.

Publications:
acs.org,
nytimes.com,
smithsonianmag.com
Topics
b.1.1.7, b.1.351, covid-19, ketamine, mutant, naloxone , nanomedicines , nmda receptor, oncology , opioids , overdoses , pharmaceuticals , sars-cov-2, vaccine, variant, antidepressants, infectious disease, pollution, science, start-ups
Recent articles
Tiny liquid droplets are driving a cell biology rethink
Oct 05, 2024
knowablemagazine.org
Making natural products ‘supernatural’
Aug 05, 2024
cen.acs.org
Ultrafast sepsis test pinpoints treatment in just 13 hours
Jul 24, 2024
cen.acs.org
New compound enhances naloxone’s ability to reverse opioid overdoses
Jul 03, 2024
cen.acs.org
Separate brain circuits drive fentanyl addiction
May 23, 2024
cen.acs.org
Prologue Medicines wants to build therapies from viral proteins
May 07, 2024
cen.acs.org
Injured orangutan seen applying medicinal plant to wound
May 03, 2024
cen.acs.org
Seaport Therapeutics launches with $100 million and a neuropsych pipeline
Apr 11, 2024
cen.acs.org
Cómo entrevistar para hacer perfiles que abarcan toda una carrera - The Open Notebook
Mar 21, 2024
theopennotebook.com
Clasp Therapeutics launches with $150 million in hand
Mar 20, 2024
cen.acs.org

Find out everything there is to know

Publication resume, most loved topics, and more. Find out everything there is to know about a journalist, in our 500k+ database.

Start a free trial of BuzzSumo.

START YOUR FREE TRIAL

Already registered? Log in to your account